HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Torp-Pedersen Selected Research

sibutramine (Meridia)

5/2015Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial.
6/2014Association between serum bilirubin and cardiovascular disease in an overweight high risk population from the SCOUT trial.
3/2014Association of anemia with the risk of cardiovascular adverse events in overweight/obese patients.
9/2012Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes.
6/2012Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial.
1/2010Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial.
3/2009Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Torp-Pedersen Research Topics

Disease

19Myocardial Infarction
01/2018 - 05/2000
10Heart Failure
01/2018 - 05/2000
10Stroke (Strokes)
01/2018 - 05/2001
9Atrial Fibrillation
01/2018 - 08/2000
8Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 02/2009
5Overweight
05/2015 - 06/2012
5Type 2 Diabetes Mellitus (MODY)
10/2014 - 11/2001
5Left Ventricular Dysfunction
07/2001 - 05/2000
4Heart Arrest (Cardiac Arrest)
12/2021 - 07/2012
4Out-of-Hospital Cardiac Arrest
01/2019 - 07/2012
4Weight Loss (Weight Reduction)
05/2015 - 03/2009
4Cardiac Arrhythmias (Arrythmia)
02/2003 - 02/2001
3Ventricular Tachycardia
01/2018 - 11/2000
3Hemorrhage
01/2018 - 01/2008
3Thromboembolism
01/2018 - 01/2008
3Ischemic Stroke
01/2018 - 08/2013
3Diabetes Mellitus
11/2011 - 06/2001
3Infarction (Infarctions)
01/2001 - 05/2000
2Psoriasis (Pustulosis Palmaris et Plantaris)
06/2015 - 02/2013
2Cardiac Sudden Death (Sudden Cardiac Arrest)
10/2014 - 07/2012
2Body Weight (Weight, Body)
01/2010 - 03/2009
2Torsades de Pointes (Torsade de Pointes)
12/2000 - 11/2000
1Brain Hypoxia (Cerebral Hypoxia)
12/2020
1Drug-Related Side Effects and Adverse Reactions
01/2017
1Necrosis
06/2015
1Obesity
03/2014
1Inflammation (Inflammations)
03/2014
1Anemia
03/2014
1Spontaneous Abortion (Miscarriage)
08/2013
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
08/2013
1Seasonal Allergic Rhinitis (Hay Fever)
11/2012
1Allergic Rhinitis
11/2012
1Lactic Acidosis
12/2010
1Weight Gain
03/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2008

Drug/Important Bio-Agent (IBA)

9Insulin (Novolin)FDA Link
10/2014 - 12/2000
7sibutramine (Meridia)FDA Link
05/2015 - 03/2009
7dofetilide (Tikosyn)FDA Link
02/2003 - 08/2000
5CreatinineIBA
03/2014 - 11/2000
4Metformin (Glucophage)FDA LinkGeneric
10/2014 - 12/2010
4Glucose (Dextrose)FDA LinkGeneric
09/2012 - 03/2003
4DiamondIBA
02/2003 - 02/2001
3AnticoagulantsIBA
01/2018 - 01/2008
3Vitamin KFDA Link
01/2018 - 02/2006
2Clopidogrel (Plavix)FDA Link
12/2014 - 12/2008
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2014 - 05/2000
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2009 - 02/2009
2pro-brain natriuretic peptide (1-76)IBA
02/2009 - 09/2008
2AlbuminsIBA
02/2009 - 09/2008
2C-Reactive ProteinIBA
02/2009 - 09/2008
2Brain Natriuretic Peptide (Natrecor)FDA Link
02/2009 - 09/2008
2Hypoglycemic Agents (Hypoglycemics)IBA
11/2001 - 12/2000
2trandolapril (Mavik)FDA LinkGeneric
06/2001 - 12/2000
2Anti-Arrhythmia AgentsIBA
12/2000 - 11/2000
1Proton Pump InhibitorsIBA
01/2018
1RivaroxabanIBA
01/2018
1apixabanIBA
01/2018
1N(4)-oleylcytosine arabinosideIBA
01/2018
1Histamine H2 AntagonistsIBA
01/2018
1DabigatranFDA Link
01/2018
1Interleukin-12 (IL 12)IBA
06/2015
1Ustekinumab (CNTO 1275)FDA Link
06/2015
1insulin receptor-related receptor (IRR)IBA
12/2014
1IncretinsIBA
10/2014
1Antipsychotic Agents (Antipsychotics)IBA
10/2014
1Dipeptidyl-Peptidase IV InhibitorsIBA
10/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
10/2014
1BilirubinIBA
06/2014
1Hemoglobins (Hemoglobin)IBA
03/2014
1IronIBA
03/2014
1Sitagliptin Phosphate (Januvia)FDA Link
03/2014
1Trimethoprim (Proloprim)FDA LinkGeneric
08/2013
1Retinaldehyde (Retinal)IBA
08/2013
1DNA (Deoxyribonucleic Acid)IBA
08/2013
1Folic Acid (Vitamin M)FDA LinkGeneric
08/2013
1Methotrexate (Mexate)FDA LinkGeneric
02/2013
1Biological ProductsIBA
02/2013
1SteroidsIBA
11/2012
1Antidepressive Agents (Antidepressants)IBA
07/2012
1Glyburide (Glibenclamide)FDA LinkGeneric
11/2011
1Cyclooxygenase InhibitorsIBA
12/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2009
1Antihypertensive Agents (Antihypertensives)IBA
03/2009
1Celecoxib (Celebrex)FDA Link
02/2009
1Naproxen (Naprosyn)FDA LinkGeneric
02/2009
1rofecoxib (Vioxx)FDA Link
02/2009
1Ibuprofen (Motrin)FDA LinkGeneric
02/2009
1Diclofenac (SR 38)FDA LinkGeneric
02/2009

Therapy/Procedure

14Therapeutics
01/2018 - 05/2000
2Resuscitation
12/2021 - 11/2018
2Percutaneous Coronary Intervention
11/2011 - 12/2008
2Thrombolytic Therapy
06/2001 - 05/2001
1Home Nursing (Nursing, Home)
12/2020
1Cardiopulmonary Resuscitation (CPR)
01/2019
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2018
1Continuous Positive Airway Pressure
12/2014
1Induced Abortion (Induced Abortions)
08/2013
1Injections
11/2012
1Immunotherapy
11/2012
1Drug Therapy (Chemotherapy)
11/2011